Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants

By Zangwill K.M.   Greenberg D.P.   Chiu C.-Y.   Mendelman P.   Wong V.K.   Chang S.-J.   Partridge S.   Ward J.I.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1894-1900

Elsevier

Access to resources Recommend Favorite

Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada

By De Wals P.   Petit G.   Erickson L.J.   Guay M.   Tam T.   Law B.   Framarin A.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3757-3764

Elsevier

Access to resources Recommend Favorite

Management of Community-Acquired Pneumonia: The Role of Clarithromycin

By Barman Balfour J.A.   Lamb H.M.  

Disease Management & Health Outcomes, Vol. 6, Iss. 4, 1999-10 ,pp. : 225-239

Adis International

Access to resources Recommend Favorite

Management of Community-Acquired Pneumonia: Defining the Role of Azithromycin

By Gunasekara N.S.   Barman Balfour J.A.  

Disease Management & Health Outcomes, Vol. 5, Iss. 1, 1999-01 ,pp. : 41-54

Adis International

Access to resources Recommend Favorite

Community-Acquired Pneumonia and its Management: The Role of Levofloxacin

By Perry C.M.   Goa K.L.  

Disease Management & Health Outcomes, Vol. 9, Iss. 1, 2001-01 ,pp. : 43-64

Adis International

Access to resources Recommend Favorite